A Phase 1, Randomized, Evaluator Blinded, Controlled Study to Evaluate the Sensitizing Potential of M518101 in Healthy Volunteers Using a Repeat Insult Patch Test Design
Phase of Trial: Phase I
Latest Information Update: 13 Aug 2015
At a glance
- Drugs Pefcalcitol (Primary) ; Sodium laurilsulfate
- Indications Plaque psoriasis
- Focus Adverse reactions
- Sponsors Maruho
- 13 Aug 2015 Status changed from active, no longer recruiting to completed.
- 04 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Oct 2014 New trial record